Kelsey Ramsden

MINDCURE Announces Additional Equity Investment in ATMA, The First Government Approved Psychedelic Journey Centers In Canada; MCUR President and CEO, Kelsey Ramsden Named to ATMA Board of Directors

Retrieved on: 
Thursday, April 8, 2021

Additionally, MINDCURE President and CEO Kelsey Ramsden will be joining the ATMA Board of Directors.

Key Points: 
  • Additionally, MINDCURE President and CEO Kelsey Ramsden will be joining the ATMA Board of Directors.
  • "We are extremely excited to strengthen our partnership with the team at ATMA through this investment.
  • ATMA's team is a true pioneer in the psychedelic therapy industry by growing a global network of group and retreat psychedelic therapy clinics," said Kelsey Ramsden, President and CEO, MINDCURE.
  • "We are thrilled today to welcome a visionary leader like Kelsey to our Board of Directors," said Vu Tran, Co-CEO of ATMA.